Recombinant erythropoietin products are utilized to treat anemia conditions caused due to renal diseases, cancer, HIV/AIDS, and other chronic illnesses.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |